<div class="container">

<table style="width: 100%;"><tr>
<td>ARMD</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Data of the Age-Related Macular Degeneration Study
</h2>

<h3>Description</h3>

<p>These are the data of a clinical trial involving patients suffering from age-related macular degeneration (ARMD), a condition that involves a progressive loss of vision. A total of <code class="reqn">181</code> patients from <code class="reqn">36</code> centers participated in the trial. Patients' visual acuity was assessed using standardized vision charts. There were two treatment conditions (placebo and interferon-<code class="reqn">\alpha</code>). The potential surrogate endpoint is the change in the visual acuity at <code class="reqn">24</code> weeks (<code class="reqn">6</code> months) after starting treatment. The true endpoint is the change in the visual acuity at <code class="reqn">52</code> weeks.</p>


<h3>Usage</h3>

<pre><code class="language-R">data(ARMD)</code></pre>


<h3>Format</h3>

<p>A <code>data.frame</code> with <code class="reqn">181</code> observations on <code class="reqn">5</code> variables.
</p>

<dl>
<dt><code>Id</code></dt>
<dd>
<p>The Patient ID.</p>
</dd>
<dt><code>Center</code></dt>
<dd>
<p>The center in which the patient was treated.</p>
</dd>
<dt><code>Treat</code></dt>
<dd>
<p>The treatment indicator, coded as <code class="reqn">-1</code> = placebo and <code class="reqn">1</code> = interferon-<code class="reqn">\alpha</code>.</p>
</dd>
<dt><code>Diff24</code></dt>
<dd>
<p>The change in the visual acuity at <code class="reqn">24</code> weeks after starting treatment. This endpoint is a potential surrogate for <code>Diff52</code>.</p>
</dd>
<dt><code>Diff52</code></dt>
<dd>
<p>The change in the visual acuity at <code class="reqn">52</code> weeks after starting treatment. This outcome serves as the true endpoint.</p>
</dd>
</dl>
</div>